https://www.diaceutics.com/
https://www.diaceutics.com/404
2022-11-03T14:26:57+00:00
https://www.diaceutics.com/500
2022-11-03T14:27:07+00:00
https://www.diaceutics.com/dxrx-terms
2023-11-30T11:20:02+00:00
https://www.diaceutics.com/register-interest
2022-11-03T15:53:07+00:00
https://www.diaceutics.com/404-draft
2022-11-03T15:17:37+00:00
https://www.diaceutics.com/terms-of-use
2022-12-15T11:50:14+00:00
https://www.diaceutics.com/dxrx-professional-services
2022-12-15T11:50:14+00:00
https://www.diaceutics.com/dxrx-security-policy
2022-12-15T11:50:14+00:00
https://www.diaceutics.com/dxrx-data-processing-addendum
2022-12-15T11:50:14+00:00
https://www.diaceutics.com/dxrx-disease-testing-rate-tracker
2023-07-25T10:06:49+00:00
https://knowtestingnow.diaceutics.com/ktn-home
2023-02-14T15:51:12+00:00
https://knowtestingnow.diaceutics.com/about-us
2023-03-02T10:38:45+00:00
https://www.diaceutics.com/contact-us
2024-01-03T09:27:29+00:00
https://www.diaceutics.com/dxrx-acceptable-use-policy
2022-12-15T11:50:14+00:00
https://www.diaceutics.com/dxrx-marketplace
2022-08-16T12:39:22+00:00
https://www.diaceutics.com/cookies-policy
2022-12-15T11:50:14+00:00
https://www.diaceutics.com/dxrx-for-pharma
2020-12-16T14:49:03+00:00
https://www.diaceutics.com/dxrx-for-diagnostic-companies
2022-08-16T13:16:04+00:00
https://www.diaceutics.com/implementation-services
2023-02-06T09:27:48+00:00
https://www.diaceutics.com/dxrx-cookies-policy
2023-07-17T14:36:20+00:00
https://www.diaceutics.com/consulting
2023-03-24T18:32:31+00:00
https://www.diaceutics.com/dxrx-sub-data-processor-list
2023-11-13T09:11:24+00:00
https://www.diaceutics.com/dxrx-support-policy
2022-12-15T11:50:14+00:00
https://www.diaceutics.com/dxrx-physician-mapping
2023-02-05T21:57:08+00:00
https://www.diaceutics.com/DXRX-signal
2023-02-05T22:02:27+00:00
https://www.diaceutics.com/partnerships
2023-02-06T09:53:37+00:00
https://www.diaceutics.com/dxrx-network-overview
2023-02-05T19:57:43+00:00
https://www.diaceutics.com/dxrx-lab-mapping
2023-02-05T21:54:36+00:00
https://www.diaceutics.com/tech-enabled-services-overview
2023-03-27T08:57:17+00:00
https://www.diaceutics.com/careers/students
2023-10-09T18:33:30+00:00
https://www.diaceutics.com/below-main-articles
2022-12-15T11:50:15+00:00
https://www.diaceutics.com/dxrx-for-labs
2023-01-10T11:22:03+00:00
https://knowtestingnow.diaceutics.com/resources
2023-02-15T15:53:21+00:00
https://knowtestingnow.diaceutics.com/knowtestingnow-home
2023-04-13T14:56:07+00:00
https://www.diaceutics.com/dxrx-data-solutions-overview
2023-02-08T10:27:30+00:00
https://knowtestingnow.diaceutics.com/practice-gaps-webinar-series
2023-05-18T11:41:33+00:00
https://knowtestingnow.diaceutics.com/practice-gaps-webinar-recordings
2023-05-22T14:40:04+00:00
https://www.diaceutics.com/acm-agenda-2024
2024-01-16T11:57:34+00:00
https://www.diaceutics.com/careers
2024-02-28T15:28:49+00:00
https://knowtestingnow.diaceutics.com/contact-us-ktn
2023-02-24T10:44:52+00:00
https://www.diaceutics.com/service-descriptions
2023-07-20T15:56:25+00:00
https://www.diaceutics.com/test-page-cookies
2023-07-17T14:37:54+00:00
https://www.diaceutics.com/articles/diaceutics-launches-worlds-first-diagnostic-network-for-precision-medicine-to-solve-global-cancer-testing-issues
2022-10-06T15:43:47+00:00
https://www.diaceutics.com/articles/diaceutics-and-alva10-partnership-to-deliver-value-based-test-reimbursement-model-for-us-payers-pharma-and-testing-providers-via-dxrx-platform
2022-10-10T09:16:16+00:00
https://www.diaceutics.com/articles/patient-mapping-designed-to-resolve-commercialization-challenges-through-deep-analysis-and-actionable-insights
2022-10-10T09:22:08+00:00
https://www.diaceutics.com/articles/diaceutics-ceo-peter-keeling-interviewed-on-the-tech-talks-daily-podcast
2022-10-10T09:27:23+00:00
https://www.diaceutics.com/articles/inefficiencies-in-the-non-small-cell-lung-cancer-patient-diagnostic-pathway-block-precision-medicine-benefits
2022-10-04T17:07:55+00:00
https://www.diaceutics.com/articles/partnerships-pharma-diagnostic-companies-important
2022-10-04T17:10:57+00:00
https://www.diaceutics.com/articles/the-impact-of-the-upcoming-ivdr-to-laboratories-and-patient-care-and-why-the-pharmaceutical-industry-should-pay-close-attention
2022-10-06T17:34:20+00:00
https://www.diaceutics.com/articles/minimal-residual-disease
2022-10-10T13:00:12+00:00
https://www.diaceutics.com/articles/diaceutics-co-authors-pivotal-paper-outlining-a-roadmap-for-the-potential-use-of-innovative-multicancer-early-detection-testing
2023-10-18T14:33:37+00:00
https://www.diaceutics.com/articles/fda-minimal-criteria-diaceutics-opinion
2023-10-18T14:42:29+00:00
https://www.diaceutics.com/articles/significant-number-of-cancer-patients-failing-to-receive-the-right-treatment
2023-10-19T09:50:49+00:00
https://www.diaceutics.com/articles/diaceutics-ceo-peter-keeling-named-in-the-business-finance-ceo-100-index-2022
2022-10-10T09:21:13+00:00
https://www.diaceutics.com/articles/diaceutics-is-recognised-in-business-finance-top-100-companies-index
2022-11-09T10:18:00+00:00
https://www.diaceutics.com/articles/diaceutics-offers-data-collaboration-opportunities-at-dataworks-headquarters-in-belfast
2022-10-04T17:26:56+00:00
https://www.diaceutics.com/articles/the-benefit-to-laboratories-in-collaborating-on-dxrx-the-diagnostic-network
2022-10-04T17:28:29+00:00
https://www.diaceutics.com/articles/diaceutics-appoints-yvanka-gilliam-as-vice-president-of-operations-asia-pacific
2022-10-06T17:35:35+00:00
https://www.diaceutics.com/articles/pharma-precision-medicine-readiness-report-2019-supplemental-update-analysis-of-fda-2019-test-dependent-therapy-approvals
2022-10-06T17:37:07+00:00
https://www.diaceutics.com/articles/diaceutics-and-lgc-seracare-partnership-expands-diagnostic-commercialization-solutions-enabled-by-global-dxrx-platform
2022-10-06T17:52:58+00:00
https://www.diaceutics.com/articles/when-rare-becomes-the-norm-part-1
2023-02-27T12:22:57+00:00
https://www.diaceutics.com/articles/diaceutics-releases-2023-trading-update
2024-02-06T16:22:08+00:00
https://www.diaceutics.com/articles/diaceutics-appoints-ken-ruppel-as-vp-of-scientific-and-medical-services
2024-02-01T16:52:16+00:00
https://www.diaceutics.com/articles/the-value-of-dxrx-the-diagnostic-network-and-the-opportunity-for-collaboration-on-the-road-to-ivdr-compliance
2022-10-10T09:52:42+00:00
https://www.diaceutics.com/articles/dxrx-features-focus-patient-mapping-lab-benchmarking
2022-10-10T11:41:10+00:00
https://www.diaceutics.com/articles/us-1m-contract-with-leading-life-sciences-company-for-data-feed-from-the-dxrx-platform
2022-10-10T11:51:45+00:00
https://www.diaceutics.com/articles/using-big-data-to-make-better-decisions-in-healthcare
2022-10-10T11:54:53+00:00
https://www.diaceutics.com/articles/diaceutics-explain-how-knime-software-is-used-to-enhance-patient-level-data
2022-10-10T12:06:02+00:00
https://www.diaceutics.com/articles/diaceutics-releases-data-highlighting-how-the-implementation-of-in-vitro-diagnostics-regulation-may-affect-the-pd-l1-testing-landscape-in-non-small-cell-lung-cancer-at-european-congress-of-pathology
2022-10-10T12:00:35+00:00
https://www.diaceutics.com/articles/diaceutics-opens-asian-hub-to-capitalize-on-growing-market
2022-10-10T12:54:13+00:00
https://www.diaceutics.com/articles/ceo-of-diaceutics-peter-keeling-shortlisted-for-entrepreneur-of-the-year-award-2018
2022-10-10T12:56:24+00:00
https://www.diaceutics.com/articles/data-from-labceutics-infectious-disease-lab-mapping-program-accepted--as-a-late-breaker-at-ictmm-2016
2022-10-10T12:57:45+00:00
https://www.diaceutics.com/articles/how-dxrx-the-diagnostic-network-can-facilitate-value-distribution-across-all-stakeholders
2021-03-23T11:25:53+00:00
https://www.diaceutics.com/articles/covid-19-delivers-a-system-shock-to-cancer-testing
2021-03-23T11:25:57+00:00
https://www.diaceutics.com/articles/ut-system-s-goonewardene-to-judge-new-100-million-macarthur-foundation-competition
2021-03-23T11:25:52+00:00
https://www.diaceutics.com/articles/diaceutics-appoints-nikita-lynn-to-vice-president-of-finance
2022-10-10T09:29:12+00:00
https://www.diaceutics.com/articles/dublin-investor-presentation
2021-03-23T11:26:11+00:00
https://www.diaceutics.com/articles/investor-presentation
2021-03-23T11:27:36+00:00
https://www.diaceutics.com/articles/fda-has-approved-philips-digital-pathology-solution-as-a-primary-diagnosis-tool-its-about-time
2021-03-23T11:27:40+00:00
https://www.diaceutics.com/articles/diaceutics-partners-with-global-eqa-providers-to-implement-best-in-class-testing-standards
2021-03-23T11:27:56+00:00
https://www.diaceutics.com/articles/covid-19-exposes-the-dire-need-for-dxrx-the-diagnostic-network-to-eradicate-the-inefficiencies-of-the-patient-diagnostic-pathway
2021-03-23T11:25:59+00:00
https://www.diaceutics.com/articles/podcast-how-diaceutics-is-repairing-the-diagnostic-testing-ecoystem-for-patients-worldwide
2021-03-23T11:27:57+00:00
https://www.diaceutics.com/articles/qa-diaceutics-ceo-keeling-provides-personalized-rx-focused-consultants-view-of-industry-progress
2021-03-23T11:28:10+00:00
https://www.diaceutics.com/articles/diaceutics-plc-announces-half-year-report-for-2020
2021-03-23T11:26:04+00:00
https://www.diaceutics.com/articles/canadian-pathology-quality-assurance-leverages-diaceutics-dxrx-platform-to-advance-ntrk-ihc-proficiency-testing
2022-10-10T11:48:26+00:00
https://www.diaceutics.com/articles/the-upcoming-ivdr-and-the-role-laboratories-and-the-pharmaceutical-industry-can-fulfill-to-support-undisrupted-patient-testing
2022-10-10T12:52:32+00:00
https://www.diaceutics.com/articles/diaceutics-research-predicts-nsclc-us-testing-market-to-reach-3-6bn-by-2025-but-solution-still-needed-to-improve-patient-outcomes
2021-03-23T11:30:16+00:00
https://www.diaceutics.com/articles/alzheimers-diagnostic
2021-03-23T11:27:35+00:00
https://www.diaceutics.com/articles/diaceutics-to-present-at-aicon-2019
2021-03-23T11:28:18+00:00
https://www.diaceutics.com/articles/diaceutics-identifies-critical-market-drivers-for-personalized-medicine-development-901163b3-df3f-4fd7-9b15-18b43ac375a8
2021-03-23T11:28:20+00:00
https://www.diaceutics.com/articles/spark-and-laboratory-data
2021-03-23T11:28:34+00:00
https://www.diaceutics.com/articles/turnaround-time-can-become-issue-laboratory-diagnostic-testing
2021-03-23T11:28:35+00:00
https://www.diaceutics.com/articles/diaceutics-strengthens-advisory-team-as-it-prepares-for-greater-patient-impact
2021-03-23T11:28:36+00:00
https://www.diaceutics.com/articles/diaceutics-reviews-the-ongoing-debate-on-diagnostics-reform-legislation
2021-03-23T11:30:27+00:00
https://www.diaceutics.com/articles/placing-of-20-5-million-to-strengthen-the-companys-balance-sheet-in-preparation-for-new-opportunities-in-commercial-diagnostic-services
2021-03-23T11:26:15+00:00
https://www.diaceutics.com/articles/much-cost-launch-pharma-diagnostic-test
2021-03-23T11:28:54+00:00
https://www.diaceutics.com/articles/an-end-to-end-drug-launch-strategy-designed-by-data-insights-at-the-global-level
2022-10-10T12:51:19+00:00
https://www.diaceutics.com/articles/diaceutics-wins-european-international-award-for-publicly-listed-companies
2021-03-23T11:26:23+00:00
https://www.diaceutics.com/articles/notice-of-results
2021-03-23T11:29:32+00:00
https://www.diaceutics.com/articles/covid-19-testing-data-licensing-agreement
2021-04-01T08:55:39+00:00
https://www.diaceutics.com/articles/diaceutics-announces-annual-results-for-2019
2021-03-23T11:26:13+00:00
https://www.diaceutics.com/articles/laboratories-hold-the-key-to-success-for-patient-care-in-precision-medicine
2021-03-23T11:26:36+00:00
https://www.diaceutics.com/articles/proficiency-testing-programs-on-dxrx-by-cpqa
2021-03-23T11:26:38+00:00
https://www.diaceutics.com/articles/new-website-highlights-diaceutics-leadership-in-personalized-medicine-focused-consulting-and-software-applications
2021-03-23T11:29:33+00:00
https://www.diaceutics.com/articles/fda-patient-voice-project-one-step-closer-to-shared-decision-making
2021-03-23T11:26:26+00:00
https://www.diaceutics.com/articles/diagnostics-leading-the-way-for-personal-health
2021-03-23T11:30:08+00:00
https://www.diaceutics.com/articles/pharma-readiness-for-personalized-medicine-summary-report-2016
2021-03-23T11:29:15+00:00
https://www.diaceutics.com/articles/2016-personalized-medicine-long-range-weather-forecast
2021-03-23T11:29:17+00:00
https://www.diaceutics.com/articles/workshop-presentation-at-eortc
2021-03-23T11:26:20+00:00
https://www.diaceutics.com/articles/executive-spotlight-yvanka-gilliam-vice-president-of-operations-asia-pacific-apac-diaceutics
2021-04-12T08:05:53+00:00
https://www.diaceutics.com/articles/levelling-up-series-part-1-time-to-level-up-testing-and-treatment
2024-02-08T16:51:53+00:00
https://www.diaceutics.com/articles/kpmg-alliance
2024-02-28T17:18:35+00:00
https://www.diaceutics.com/articles/engaging-with-laboratories-personalized-medicine-what-pharma-should-do-to-get-ready
2021-03-23T11:29:30+00:00
https://www.diaceutics.com/articles/dxrx-the-diagnostic-network-the-collaborative-solution-to-the-broken-clinical-diagnostic-testing-ecosystem-is-here
2021-03-23T11:26:30+00:00
https://www.diaceutics.com/articles/diaceutics-shortlisted-for-top-100-hot-start-ups-in-ireland
2021-03-23T11:28:01+00:00
https://www.diaceutics.com/articles/labs-interested-in-ntrk-ihc-proficiency-testing-will-be-at-the-front-row-of-quality-on-dxrx
2021-03-23T11:26:31+00:00
https://www.diaceutics.com/articles/nov-30-blog-on-data-pharma-benes
2021-03-23T11:26:32+00:00
https://www.diaceutics.com/articles/summary-of-non-regulatory-news-and-coverage-in-the-last-quarter-of-2020
2021-03-23T11:26:33+00:00
https://www.diaceutics.com/articles/the-road-to-recovery-how-covid-19-has-impacted-the-global-oncology-diagnostic-testing-environment
2021-03-23T11:26:44+00:00
https://www.diaceutics.com/articles/onclive-interviews-diaceutics-at-eha-congress-2019-retesting-for-flt3-mutation-status-in-aml
2021-03-23T11:29:34+00:00
https://www.diaceutics.com/articles/the-depth-of-the-data-on-dxrx-the-diagnostic-network-enables-a-launch-strategy-that-leaves-no-patient-behind
2021-04-06T10:27:17+00:00
https://www.diaceutics.com/articles/moving-beyond-the-hype-the-reality-of-ngs-in-oncology-today-and-in-the-future
2021-03-23T11:26:45+00:00
https://www.diaceutics.com/articles/medtech-expert-diaceutics-passes-global-pharma-test
2021-03-23T11:29:57+00:00
https://www.diaceutics.com/articles/diaceutics-joins-nineteen-leading-healthcare-companies-to-form-covid-19-testing-industry-consortium
2021-03-23T11:27:37+00:00
https://www.diaceutics.com/articles/which-pharma-companies-are-dx-ready-for-precision-medicine-in-2017-benchmarking-financial-risks-and-predictions
2021-03-23T11:26:48+00:00
https://www.diaceutics.com/articles/pharmavoice-100-celebration-marathon
2021-03-23T11:26:56+00:00
https://www.diaceutics.com/articles/a-dose-of-reality-laboratories-need-to-be-a-key-priority-in-companion-diagnostics
2021-03-23T11:29:48+00:00
https://www.diaceutics.com/articles/diaceutics-launches-significant-upgrade-to-its-dxrx-platform
2024-03-22T10:31:45+00:00
https://www.diaceutics.com/articles/crohns-disease-treatment-become-precise
2021-03-23T11:28:29+00:00
https://www.diaceutics.com/articles/which-pharma-companies-are-ready-for-diagnostic-integration-in-2017
2021-03-23T11:30:02+00:00
https://www.diaceutics.com/articles/diaceutics-ceo-peter-keeling-interviewed-on-rte-radio-1-about-latest-4m-funding-round-from-silicon-valley-bank-precision-medicine
2021-03-23T11:26:42+00:00
https://www.diaceutics.com/articles/diaceutics-alva10-gathering-evidence-base-for-improving-pd-l1-test-reimbursement
2021-03-23T11:26:43+00:00
https://www.diaceutics.com/articles/ngs-genetic-testing
2021-03-23T11:28:30+00:00
https://www.diaceutics.com/articles/challenges-in-the-clinical-implementation-of-precision-medicine-companion-diagnostics
2021-03-23T11:30:42+00:00
https://www.diaceutics.com/articles/the-digitalization-of-the-companion-diagnostic-process-as-the-innovative-accelerator-of-success-for-precision-therapy-development-and-adoption
2021-04-13T16:20:15+00:00
https://www.diaceutics.com/articles/unlock-access-to-biomarker-testing-rates
2022-08-17T15:53:57+00:00
https://www.diaceutics.com/articles/q-diaceutics-jordan-clark-on-industry-fda-gap-on-rx-dx-codevelopment-principles
2021-03-23T11:31:21+00:00
https://www.diaceutics.com/articles/culture-values-relaunch-at-diaceutics
2022-06-10T14:15:32+00:00
https://www.diaceutics.com/articles/what-are-the-major-differences-in-biomarker-test-adoption-in-european-countries-an-analysis-of-pd-l1-testing-in-italy-and-germany
2021-03-23T11:26:46+00:00
https://www.diaceutics.com/articles/how-can-analytics-help-avoid-the-pd-l1-chaos-10-years-of-insights
2021-03-23T11:26:49+00:00
https://www.diaceutics.com/articles/personalized-medicine-what-are-the-up-and-coming-therapeutic-areas-in-non-oncology
2021-03-23T11:26:50+00:00
https://www.diaceutics.com/articles/leave-no-patient-behind-how-the-fda-approval-of-keytruda-for-specific-biomarkers-will-put-laboratory-testing-in-the-front-line
2021-03-23T11:30:14+00:00
https://www.diaceutics.com/articles/diaceutics-wins-at-export-industry-awards
2021-03-23T11:32:57+00:00
https://www.diaceutics.com/articles/diaceutics-global-data-repository-leads-the-way-to-smarter-data-enabled-precision-medicine-at-asco-2020
2022-10-10T12:47:08+00:00
https://www.diaceutics.com/articles/is-pharma-leveraging-the-diagnostic-in-targeted-therapy-branding-and-communications
2021-03-23T11:26:51+00:00
https://www.diaceutics.com/articles/is-pharma-ready-for-personalized-medicine-9-steps-to-set-you-on-your-way
2021-03-23T11:31:06+00:00
https://www.diaceutics.com/articles/576
2021-03-23T11:26:52+00:00
https://www.diaceutics.com/articles/diaceutics-wins-made-in-northern-ireland-2019-award
2021-03-23T11:30:44+00:00
https://www.diaceutics.com/articles/pd-l1-story-far
2021-03-23T11:30:46+00:00
https://www.diaceutics.com/articles/sea-breezes-sunshine-diaceutics-cyclists
2021-03-23T11:30:48+00:00
https://www.diaceutics.com/articles/results-of-general-meeting
2021-03-23T11:30:56+00:00
https://www.diaceutics.com/articles/global-laboratory-landscape-data-for-targeted-pharma-therapy-launches-are-you-ready
2021-03-23T11:26:53+00:00
https://www.diaceutics.com/articles/diaceutics-presents-poster-at-esmo-congress-2019
2021-03-23T11:31:01+00:00
https://www.diaceutics.com/articles/the-value-of-diagnostic-pre-launch-planning-for-targeted-therapies-through-the-pd-l1-lens
2021-03-23T11:26:55+00:00
https://www.diaceutics.com/articles/integration-standardization-and-diagnostics-oversight-of-laboratory-testing
2021-03-23T11:31:07+00:00
https://www.diaceutics.com/articles/new-digital-solution-helps-pharma-maximize-precision-medicine-launch-and-achieve-peak-therapy-prescription-numbers
2021-03-23T11:26:58+00:00
https://www.diaceutics.com/articles/realizing-the-value-of-precision-medicine-today
2021-03-23T11:28:41+00:00
https://www.diaceutics.com/articles/worldwide-business-with-kathy-ireland-interviews-diaceutics
2021-03-23T11:31:10+00:00
https://www.diaceutics.com/articles/cancer-testing-and-diagnosis-suffers-sharp-downturn-finds-diaceutics
2021-03-23T11:31:11+00:00
https://www.diaceutics.com/articles/diaceutics-announces-name-change-for-company-divisions
2021-03-23T11:31:17+00:00
https://www.diaceutics.com/articles/diaceutics-plc-announces-it-will-release-its-preliminary-results-for-last-year-on-march-16
2021-03-23T11:31:19+00:00
https://www.diaceutics.com/articles/levelling-up-series-part-2-precision-testing-s-suboptimal-hta-time-to-level-up
2024-02-08T16:47:30+00:00
https://www.diaceutics.com/articles/diaceutics-joins-signatories-urging-cms-to-expand-national-coverage-of-ngs-testing-for-cancer-patients
2021-03-23T11:28:02+00:00
https://www.diaceutics.com/articles/ntrk-gene-fusion-adoption-readiness-in-3-european-countries
2021-03-23T11:27:01+00:00
https://www.diaceutics.com/articles/diaceutics-receives-nomination-for-international-star-in-the-european-small-and-mid-cap-awards-2020
2021-03-23T11:31:33+00:00
https://www.diaceutics.com/articles/bioceutics-wins-first-place-award-at-dxma-global-marketing-summit
2021-03-23T11:31:38+00:00
https://www.diaceutics.com/articles/a-way-forward-leveraging-advanced-diagnostic-testing-to-unlock-the-value-of-precision-medicine-564a9b27-f030-4f5e-b184-01be6c5379b5
2021-03-23T11:31:39+00:00
https://www.diaceutics.com/articles/why-collaboration-is-the-new-norm-in-precision-medicine
2021-03-23T11:27:02+00:00
https://www.diaceutics.com/articles/pik3ca-testing-adoption-readiness-for-breast-cancer-in-9-european-countries
2021-03-23T11:27:03+00:00
https://www.diaceutics.com/articles/italian-virology-society-congress-2017
2021-03-23T11:31:53+00:00
https://www.diaceutics.com/articles/lag-3-new-biomarker-under-investigation-in-immunooncology
2021-03-23T11:32:06+00:00
https://www.diaceutics.com/articles/nick-roberts-joins-diaceutics-as-chief-financial-officer
2022-03-25T16:12:23+00:00
https://www.diaceutics.com/articles/stability-of-rare-tp53-co-mutations-in-aml-patients-959fcd04-e67f-4e1d-b120-1a5b68237884
2021-03-23T11:32:07+00:00
https://www.diaceutics.com/articles/in-vitro-diagnostic-regulation-readiness-collaboration-opportunities-now-live-on-dxrx-the-diagnostic-network
2021-03-23T11:27:04+00:00
https://www.diaceutics.com/articles/issue-of-share-options
2021-03-23T11:27:05+00:00
https://www.diaceutics.com/articles/peter-keeling-interviewed-by-irelands-newstalk-breakfast-business-13-april-2017
2021-03-23T11:27:47+00:00
https://www.diaceutics.com/articles/cancer-patients-face-delays-getting-potentially-lifesaving-biomarker-tests
2021-03-23T11:28:03+00:00
https://www.diaceutics.com/articles/diagnostic-channel-to-prescribers-in-precision-medicine
2023-12-12T15:58:53+00:00
https://www.diaceutics.com/articles/braf-mutation
2021-03-23T11:27:11+00:00
https://www.diaceutics.com/articles/julie-browne-joins-diaceutics-as-chief-operating-officer
2022-10-06T15:42:06+00:00
https://www.diaceutics.com/articles/diaceutics-appoints-seasoned-business-leader-deborah-davis-as-non-executive-chair
2022-10-10T09:08:48+00:00
https://www.diaceutics.com/articles/establish-if-flt3-testing-behavior-in-relapsed-aml-has-evolved
2021-03-23T11:34:08+00:00
https://www.diaceutics.com/articles/diaceutics-raises-5m-from-whiterock-capital-partners-and-silicon-valley-bank-to-support-global-expansion
2021-03-23T11:32:47+00:00
https://www.diaceutics.com/articles/positive-start-to-the-financial-year
2021-03-23T11:27:49+00:00
https://www.diaceutics.com/articles/letter-from-efpia-ecpc-and-diaceutics-calls-for-postponed-application-and-phased-implementation-of-the-in-vitro-diagnostic-regulation
2021-05-28T11:48:17+00:00
https://www.diaceutics.com/articles/diaceutics-brings-professional-learning-and-support-courses-to-dxrx-members-through-new-labvine-partnership
2021-04-30T10:15:58+00:00
https://www.diaceutics.com/articles/diaceutics-releases-two-posters-presented-at-amp-2021
2022-12-20T13:50:08+00:00
https://www.diaceutics.com/articles/dxrx-and-siapec-educational-webinar-series-for-pd-l1-testing-for-clinical-utility
2021-05-17T12:03:02+00:00
https://www.diaceutics.com/articles/diaceutics-asco-2021-review-podcast
2021-06-14T15:52:10+00:00
https://www.diaceutics.com/articles/pushing-forward-with-precision-medicine-how-deep-data-analysis-will-change-the-patient-journey
2021-03-23T11:33:21+00:00
https://www.diaceutics.com/articles/aml-genetic-testing
2021-03-23T11:33:24+00:00
https://www.diaceutics.com/articles/two-new-experts-join-the-diaceutics-advisory-panel
2022-11-09T10:26:27+00:00
https://www.diaceutics.com/articles/diaceutics-to-release-breakthrough-data-on-covid-19-impact-on-cancer-at-2021-american-society-of-clinical-oncology-asco-meeting
2022-10-13T14:30:17+00:00
https://www.diaceutics.com/articles/cycle-race-boosts-funds-for-belfast-charity
2021-03-23T11:33:25+00:00
https://www.diaceutics.com/articles/diaceutics-pharma-precision-medicine-readiness-report-2019-its-time-to-rethink-the-testing-treatment-relationship
2021-03-23T11:33:26+00:00
https://www.diaceutics.com/articles/pharma-readiness-for-diagnostic-integration-2017
2021-03-23T11:33:33+00:00
https://www.diaceutics.com/articles/liquid-biopsy-clearing-barriers-support-pharma-labs-patients
2021-03-23T11:34:09+00:00
https://www.diaceutics.com/articles/diaceutics-announces-the-launch-of-its-real-time-test-signal-service-in-the-us
2021-12-09T09:59:40+00:00
https://www.diaceutics.com/articles/to-test-or-not-to-test-avoiding-costly-planning-mistakes-with-effective-dx-financial-pre-launch-planning
2021-03-23T11:34:15+00:00
https://www.diaceutics.com/articles/navigating-precision-medicine-challenges-in-imids
2024-02-21T14:09:20+00:00
https://www.diaceutics.com/articles/ensure-diverse-internal-capabilities-in-a-personalized-medicine-pharma-company-personalized-medicine-what-pharma-should-do-to-get-ready
2021-03-23T11:34:28+00:00
https://www.diaceutics.com/articles/diaceutics-releases-data-highlighting-the-readiness-of-eu4-labs-providing-fgfr2-fusion-testing-using-ngs-in-a-clinical-setting
2021-10-28T15:02:33+00:00
https://www.diaceutics.com/articles/diaceutics-wins-award-for-ipo-of-the-year-at-2020-small-cap-awards-c155f7b0-ef1f-4031-a527-8782502be164
2021-03-23T11:27:50+00:00
https://www.diaceutics.com/articles/product-update-dxrx-collaborations-search-enhancement
2021-09-01T11:57:46+00:00
https://www.diaceutics.com/articles/the-shift-towards-patient-centricity-personalized-medicine-what-pharma-should-do-to-get-ready-series
2023-10-16T16:03:44+00:00
https://www.diaceutics.com/articles/partnering-and-managing-partnerships-personalized-medicine-what-pharma-should-do-to-get-ready-series
2021-03-23T11:34:32+00:00
https://www.diaceutics.com/articles/whatever-anything-is-it-ought-to-begin-by-being-personal
2021-03-23T11:34:34+00:00
https://www.diaceutics.com/articles/diaceutics-win-multiple-contracts-for-inherited-retinal-disease-ird-in-apac-eu-and-us-markets
2021-06-24T09:48:35+00:00
https://www.diaceutics.com/articles/diaceutics-are-finalists-in-four-categories-at-health-tech-awards-2021
2021-11-10T15:38:39+00:00
https://www.diaceutics.com/articles/diagnostic-commercialization
2021-03-23T11:27:16+00:00
https://www.diaceutics.com/articles/annual-report-2019
2021-07-08T12:01:13+00:00
https://www.diaceutics.com/articles/voices-of-stakeholders-powerful-in-achieving-success-as-cms-rescinds-retirement-of-diagnosis-codes
2022-06-29T14:17:17+00:00
https://www.diaceutics.com/articles/diaceutics-and-seap-collaborate-on-new-study-impact-of-the-esgo-and-iccr-guidelines-in-the-diagnosis-of-endometrial-cancer-in-spain
2021-06-02T15:54:22+00:00
https://www.diaceutics.com/articles/diaceutics-welcomes-data-analytics-students-onto-new-placement-programme
2021-11-10T15:36:25+00:00
https://www.diaceutics.com/articles/diaceutics-are-finalists-in-the-2021-fierce-healthcare-innovation-awards
2022-03-31T09:17:58+00:00
https://www.diaceutics.com/articles/patient-access-to-innovations-in-precision-medicine-accelerated-by-an-evidence-based-strategy-to-launch
2021-03-26T10:08:00+00:00
https://www.diaceutics.com/articles/peter-keeling-shortlisted-for-top-100-most-inspiring-people-in-pharma
2021-03-23T11:27:51+00:00
https://www.diaceutics.com/articles/diaceutics-finds-156k-cancer-patients-could-miss-out-on-life-saving-drugs-every-year-in-us-and-europe
2021-03-23T11:27:44+00:00
https://www.diaceutics.com/articles/diaceutics-impact-of-esgo-and-iccr-guidelines-study-extended-to-uk-full-report-available-on-dxrx
2021-07-30T09:45:04+00:00
https://www.diaceutics.com/articles/diaceutics-and-rxmx-will-collaborate-to-solve-challenges-in-the-testing-ecosystem
2022-11-09T10:24:37+00:00
https://www.diaceutics.com/articles/the-6-barriers-to-seamless-diagnostic-testing
2022-05-10T16:30:18+00:00
https://www.diaceutics.com/articles/efpia-ecpc-diaceutics-call-for-postponed-application-phased-implementation-of-in-vitro-diagnostic-regulation
2021-05-28T11:57:15+00:00
https://www.diaceutics.com/articles/admission-to-trading-on-aim-and-first-day-of-dealings
2021-03-23T11:27:41+00:00
https://www.diaceutics.com/articles/new-lease-agreement-related-party-transaction-change-of-registered-office-from-july-2021
2021-03-30T17:49:10+00:00
https://www.diaceutics.com/articles/levelling-up-series-part-3-the-systemic-shadow-hanging-over-the-value-of-diagnostics
2024-03-26T16:04:00+00:00
https://www.diaceutics.com/articles/dxrx-features-focus-physician-mapping-data-tools
2021-07-30T12:45:06+00:00
https://www.diaceutics.com/articles/gain-valuable-insights-from-dxrx-the-diagnostic-network-data-to-commercialise-your-therapy
2022-03-31T09:18:05+00:00
https://www.diaceutics.com/articles/diaceutics-announces-two-poster-presentations-at-amp-2021-annual-meeting-expo
2021-09-13T13:10:18+00:00
https://www.diaceutics.com/articles/diaceutics-invests-additional-1-million-in-patient-data-to-improve-outcomes
2021-03-23T11:27:14+00:00
https://www.diaceutics.com/articles/with-new-partnerships-diaceutics-works-to-standardize-cdx-testing-globally
2022-10-10T12:01:35+00:00
https://www.diaceutics.com/articles/drug-pricing-models
2021-03-23T11:27:18+00:00
https://www.diaceutics.com/articles/emerging-company-in-the-spotlight
2021-03-23T11:27:20+00:00
https://www.diaceutics.com/articles/holdings-in-company-2
2021-03-23T11:27:21+00:00
https://www.diaceutics.com/articles/getting-great-view-companion-diagnostic-landscape
2021-03-23T11:27:23+00:00
https://www.diaceutics.com/articles/diaceutics-appoints-mark-reis-as-senior-vice-president-of-business-development-and-marketing
2021-03-23T11:27:25+00:00
https://www.diaceutics.com/articles/taking-pain-diagnostic-approval-process
2021-03-23T11:27:27+00:00
https://www.diaceutics.com/articles/tiffany-olson-formerly-of-eli-lilly-and-company-appointed-chairman-of-board-of-advisors-of-diaceutics
2021-03-23T11:27:28+00:00
https://www.diaceutics.com/articles/payer-research
2021-03-23T11:28:14+00:00
https://www.diaceutics.com/articles/next-generation-sequencing
2021-03-23T11:27:31+00:00
https://www.diaceutics.com/articles/pharma-finance-and-the-trump-effect
2021-03-23T11:28:07+00:00
https://www.diaceutics.com/articles/diaceutics-convenes-pharmaceutical-and-diagnostic-industry-leaders-to-identify-financial-benchmarks-essential-to-successful-co-development-of-personalized-medicine
2021-03-23T11:28:08+00:00
https://www.diaceutics.com/articles/in-bid-to-improve-access-to-personalized-medicines-diaceutics-to-develop-platform-connecting-pharmaceutical-companies-with-diagnostic-testing-partners
2021-03-23T11:28:21+00:00
https://www.diaceutics.com/articles/diaceutics-launches-labceutics-laboratory-network-in-europe-in-support-of-growing-personalized-medicine-market
2021-03-23T11:28:22+00:00
https://www.diaceutics.com/articles/personalised-medicine-consultancy-diaceutics-to-create-20-jobs-over-3-years-in-ireland
2021-03-23T11:28:26+00:00
https://www.diaceutics.com/articles/diaceutics-mission-of-partnerships-in-companion-diagnostics-resonates-with-the-themes-of-aacr-2019
2021-03-23T11:28:27+00:00
https://www.diaceutics.com/articles/pd-l1-the-story-so-far
2021-03-23T11:28:28+00:00
https://www.diaceutics.com/articles/diaceutics-report-sheds-doubt-on-pharmas-personalized-medicine-preparedness
2021-03-23T11:28:31+00:00
https://www.diaceutics.com/articles/why-pm-1-0-will-not-create-radical-healthcare-change-prompting-the-need-for-pm-2-0
2020-07-14T09:34:38+00:00
https://www.diaceutics.com/articles/pharma-readiness-for-diagnostic-integration-2017-35b4599e-a3f0-4179-9e50-ba97ccb5634c
2021-03-23T11:28:42+00:00
https://www.diaceutics.com/articles/diaceutics-appoints-damian-thornton-as-chief-operating-officer
2021-03-23T11:28:43+00:00
https://www.diaceutics.com/articles/a-new-international-collaborative-has-been-formed-to-help-remove-barriers-limiting-the-promise-of-personalizedprecision-medicine
2021-03-23T11:28:45+00:00
https://www.diaceutics.com/articles/looking-the-wrong-way-to-fix-a-broken-diagnostic-testing-ecosystem
2021-03-23T11:28:49+00:00
https://www.diaceutics.com/articles/pm-readiness-report-2018-summary
2021-03-23T11:28:55+00:00
https://www.diaceutics.com/articles/podcast-pm-readiness-report-2018
2021-03-23T11:29:01+00:00
https://www.diaceutics.com/articles/tackling-uphill-challenge-cancer-research
2021-03-23T11:29:02+00:00
https://www.diaceutics.com/articles/diaceutics-is-developing-a-data-science-platform-in-belfast-to-improve-patient-diagnostic-testing-globally-2
2021-03-23T11:29:24+00:00
https://www.diaceutics.com/articles/test-availability-at-launch-can-be-underestimated-under-budgeted-and-under-resourced-an-example-using-real-time-real-world-analysis-of-pd-l1
2021-03-23T11:29:08+00:00
https://www.diaceutics.com/articles/biomarker-qualification
2021-03-23T11:29:19+00:00
https://www.diaceutics.com/articles/diaceutics-ryan-keeling-named-in-prestigious-pharma-list
2021-03-23T11:29:22+00:00
https://www.diaceutics.com/articles/annual-diaceutics-report-illuminates-state-of-diagnostic-ecosystem-in-the-pharmaceutical-industry
2021-03-23T11:29:23+00:00
https://www.diaceutics.com/articles/liquid-biopsy-in-nsclc
2021-03-23T11:29:28+00:00
https://www.diaceutics.com/articles/diaceutics-group-launches-iceutics-personalized-medicine-expert-resources-for-targeted-therapy-commercialization-planning
2021-03-23T11:29:35+00:00
https://www.diaceutics.com/articles/great-expectations-for-personalized-medicine-outside-oncology
2021-03-23T11:29:36+00:00
https://www.diaceutics.com/articles/diaceutics-names-steve-vitale-managing-director-of-analytics-insights-and-strategy-division
2021-03-23T11:29:37+00:00
https://www.diaceutics.com/articles/peter-keeling-i-saw-very-early-on-how-a-disease-can-be-transformed-by-the-pharma-industry-it-was-my-inspiration
2021-03-23T11:29:39+00:00
https://www.diaceutics.com/articles/cahg-and-diaceutics-partner-to-develop-marketing-and-communication-campaigns-specific-to-personalized-healthcare
2021-03-23T11:29:40+00:00
https://www.diaceutics.com/articles/diaceutics-appoints-julie-goonewardene-chair-of-its-advisory-board
2021-03-23T11:29:41+00:00
https://www.diaceutics.com/articles/asuragen-and-labceutics-report-results-from-pan-european-quality-assurance-modeled-study-on-standardization-of-bcr-abl1-monitoring-for-cml-patients
2021-03-23T11:29:42+00:00
https://www.diaceutics.com/articles/diaceutics-reviews-the-ongoing-debate-on-diagnostics-reform-legislation-d5129b24-9e34-4ba1-9b63-9e17bd95eb5e
2021-03-23T11:30:03+00:00
https://www.diaceutics.com/articles/diaceutics-use-artificial-intelligence-improve-diagnosis-treatment-patients
2021-03-23T11:30:06+00:00
https://www.diaceutics.com/articles/shortlists-revealed-for-made-in-northern-ireland-awards-2019
2021-03-23T11:30:19+00:00
https://www.diaceutics.com/articles/peter-keeling-interview-owning-the-diagnostic-journey
2021-03-23T11:30:12+00:00
https://www.diaceutics.com/articles/diaceutics-shortlisted-for-irish-times-business-awards-2019
2021-03-23T11:30:22+00:00
https://www.diaceutics.com/articles/holdings-in-company
2021-03-23T11:30:23+00:00
https://www.diaceutics.com/articles/running-support-dogs-different-kind-personalized-medicine
2021-03-23T11:30:25+00:00
https://www.diaceutics.com/articles/trading-update
2021-03-23T11:30:26+00:00
https://www.diaceutics.com/articles/diaceutics-plc-half-year-report
2021-03-23T11:30:31+00:00
https://www.diaceutics.com/articles/appointment-of-head-of-global-data
2021-03-23T11:30:32+00:00
https://www.diaceutics.com/articles/patient-power
2021-03-23T11:30:36+00:00
https://www.diaceutics.com/articles/trk-fusion-positive-cancers-from-first-clinical-data-of-a-trk-inhibitor-to-future-directions
2021-03-23T11:30:45+00:00
https://www.diaceutics.com/articles/directors-shareholding---pca-dealing
2021-03-23T11:30:47+00:00
https://www.diaceutics.com/articles/presentation-at-big-data-belfast
2021-03-23T11:30:53+00:00
https://www.diaceutics.com/articles/real-time-oncology-review
2021-03-23T11:30:54+00:00
https://www.diaceutics.com/articles/chief-commercial-officer-at-diaceutics-jordan-clark-to-join-subject-matter-experts-at-kantar-health-to-discuss-applying-new-assumptions-in-uncertain-times-covid-19
2021-03-23T11:30:55+00:00
https://www.diaceutics.com/articles/challenges-in-the-clinical-implementation-of-precision-medicine-companion-diagnostics-5cb7496f-655b-4e8e-a072-b27537505da7
2021-03-23T11:30:59+00:00
https://www.diaceutics.com/articles/leveraging-real-world-testing-data-to-unlock-the-promise-of-precision-medicine
2021-03-23T11:31:27+00:00
https://www.diaceutics.com/articles/no-single-pharma-model-for-commercialization-of-biomarkers-view-from-a-companion-diagnostics-company
2021-03-23T11:31:00+00:00
https://www.diaceutics.com/articles/diaceutics-announces-that-it-has-received-notification-for-the-exercise-of-a-warrant-over-ordinary-shares
2021-03-23T11:31:04+00:00
https://www.diaceutics.com/articles/fora-interviews-the-man-behind-diaceutics
2021-03-23T11:31:14+00:00
https://www.diaceutics.com/articles/diaceutics-to-become-first-anchor-tenant-at-proposed-kings-hall-wellbeing-park
2021-03-23T11:31:15+00:00
https://www.diaceutics.com/articles/pharmavoice-speaks-to-our-newly-appointed-chief-precision-officer-susanne-munksted-for-the-latest-podcast-in-their-woman-of-the-week-series
2021-03-23T11:31:18+00:00
https://www.diaceutics.com/articles/diaceutics-announces-worlds-first-diagnostic-network-for-precision-medicine-following-%C2%A323m-investment
2021-03-23T11:31:24+00:00
https://www.diaceutics.com/articles/diaceutics-collaborates-with-industry-advisor-network-to-publish-multiple-cancer-insights
2021-03-23T11:31:25+00:00
https://www.diaceutics.com/articles/diaceutics-announces-30-jobs-on-back-of-60-revenue-growth
2021-03-23T11:32:58+00:00
https://www.diaceutics.com/articles/belfast-investor-presentation-postponement
2021-03-23T11:31:28+00:00
https://www.diaceutics.com/articles/diaceutics-announces-the-issuance-of-share-options
2021-03-23T11:31:31+00:00
https://www.diaceutics.com/articles/diaceutics-plc-aim-dxrx-exceeds-full-year-guidance-reporting-strong-finish-to-2019-financial-year
2021-03-23T11:31:55+00:00
https://www.diaceutics.com/articles/diaceutics-plc-market-opening-ceremony-at-the-london-stock-exchange-to-mark-the-first-day-of-dealings-on-aim
2021-03-23T11:31:34+00:00
https://www.diaceutics.com/articles/precision-medicine-pm-and-artificial-intelligence-ai-algorithms-risk-of-bias-in-treatment
2021-03-23T11:31:35+00:00
https://www.diaceutics.com/articles/drive-diagnostic-testing
2021-03-23T11:31:37+00:00
https://www.diaceutics.com/articles/diaceutics-contributes-to-the-evolving-dialogue-on-precision-medicine-and-companion-diagnostics-in-its-editorial-published-in-precision-cancer-medicine-pcm-march-2019
2021-03-23T11:31:40+00:00
https://www.diaceutics.com/articles/cms-decision-on-ngs-coverage-is-a-big-step-forward-for-patients-and-laboratories
2021-03-23T11:32:04+00:00
https://www.diaceutics.com/articles/diaceutics-plc-aim-dxrx-the-diagnostic-commercialisation-company-announces-it-will-be-exhibiting-at-the-growth--innovation-forum-2020
2021-03-23T11:31:41+00:00
https://www.diaceutics.com/articles/diaceutics-report-identifies-future-pharmaceutical-leaders-in-personalized-medicine
2021-03-23T11:31:43+00:00
https://www.diaceutics.com/articles/culminatum-innovation-and-diaceutics-collaborate-to-provide-expert-training-to-leading-finnish-researchers-on-commercializing-biomarkers-for-personalized-medicine
2021-03-23T11:31:50+00:00
https://www.diaceutics.com/articles/fear-of-theranostics-abstract
2021-03-23T11:31:54+00:00
https://www.diaceutics.com/articles/laboratory-diagnostic-tests
2021-03-23T11:31:59+00:00
https://www.diaceutics.com/articles/trends-in-flt3-testing
2021-03-23T11:32:03+00:00
https://www.diaceutics.com/articles/pd-l1-biomarker
2021-03-23T11:32:08+00:00
https://www.diaceutics.com/articles/laboratory-turnaround-time
2021-03-23T11:32:10+00:00
https://www.diaceutics.com/articles/diaceutics-calls-for-global-harmonization-of-diagnostic-testing
2021-03-23T11:32:11+00:00
https://www.diaceutics.com/articles/companion-diagnostics-market
2021-03-23T11:33:08+00:00
https://www.diaceutics.com/articles/from-boardroom-to-bike-philip-cycles-for-cancer
2021-03-23T11:33:02+00:00
https://www.diaceutics.com/articles/a-new-disease-level-precision-medicine-model-starting-with-melanoma
2021-03-23T11:33:17+00:00
https://www.diaceutics.com/articles/data-for-life-new-partnership-with-ibms-is-another-step-forward-in-accelerating-market-penetration
2021-03-23T11:32:31+00:00
https://www.diaceutics.com/articles/drugging-the-undruggable-a-market-readiness-analysis-for-kras-g12c
2021-03-23T11:32:33+00:00
https://www.diaceutics.com/articles/esmo-2019
2021-03-23T11:32:34+00:00
https://www.diaceutics.com/articles/how-can-real-time-analysis-of-the-pd-l1-testing-market-boost-precision-medicine
2021-03-23T11:32:44+00:00
https://www.diaceutics.com/articles/transforming-the-pharma-business-model-to-prevent-lost-treatment-opportunities-and-optimize-return-on-investment
2021-03-23T11:32:48+00:00
https://www.diaceutics.com/articles/new-report-reveals-most-leading-pharma-companies-still-not-commercially-ready-for-personalized-medicine-business-model
2021-03-23T11:32:54+00:00
https://www.diaceutics.com/articles/5-reasons-to-meet-diaceutics-at-asco
2021-03-23T11:32:55+00:00
https://www.diaceutics.com/articles/what-can-pharma-do-to-get-ahead-of-their-pm-competitors
2021-03-23T11:33:14+00:00
https://www.diaceutics.com/articles/diaceutics-wins-award-for-ipo-of-the-year-at-2020-small-cap-awards
2023-01-31T11:17:37+00:00
https://www.diaceutics.com/articles/braf-mutation-testing-in-melanoma-poster-presented-at-european-congress-of-pathology-2018
2021-03-23T11:33:18+00:00
https://www.diaceutics.com/articles/companion-diagnostics-driving-new-model-for-pharma-dx-partnerships
2021-03-23T11:33:19+00:00
https://www.diaceutics.com/articles/diaceutics-growth-reflects-the-rise-in-diagnostic-use
2021-03-23T11:33:23+00:00
https://www.diaceutics.com/articles/better-testing
2021-03-23T11:33:28+00:00
https://www.diaceutics.com/articles/personalized-medicine-what-pharma-should-do-to-get-ready
2021-03-23T11:33:30+00:00
https://www.diaceutics.com/articles/diaceutics-suite-of-companion-diagnostic-commercialization-services-puts-patients-first-at-asco-2019
2021-03-23T11:33:32+00:00
https://www.diaceutics.com/articles/diaceutics-partners-with-targos-and-histocyte-laboratories-to-drive-global-diagnostic-testing-standardization
2022-10-10T13:05:43+00:00
https://www.diaceutics.com/articles/eu-ivd-regulation
2021-03-23T11:33:43+00:00
https://www.diaceutics.com/articles/diagnostic-adoption
2021-03-23T11:34:06+00:00
https://www.diaceutics.com/articles/diagnostics-strategy
2021-03-23T11:34:33+00:00
https://www.diaceutics.com/articles/diaceutics-reveals-data-highlighting-changes-in-management-of-tnbc-during-the-covid-19-pandemic-in-2020
2023-10-16T17:29:33+00:00
https://www.diaceutics.com/articles/pharmavoice-2020-year-in-preview-features-precision-medicine-insight-of-ceo-of-diaceutics-peter-keeling
2021-03-23T11:34:07+00:00
https://www.diaceutics.com/articles/white-paper-principles-for-codevelopment-of-an-in-vitro-companion-diagnostic-device-with-a-therapeutic-product
2021-03-23T11:34:12+00:00
https://www.diaceutics.com/articles/new-contract-win-for-dxrx-platform
2021-03-23T11:34:13+00:00
https://www.diaceutics.com/articles/global-laboratory-landscape-data-and-strategy-for-targeted-therapy-launches-understanding-cdx-intelligence-and-trends
2021-03-23T11:34:17+00:00
https://www.diaceutics.com/articles/the-cms-national-coverage-decision-on-ngs
2023-07-25T10:41:04+00:00
https://www.diaceutics.com/articles/7-commentaries-on-the-2017-diagnostic-marketplace
2021-03-23T11:34:18+00:00
https://www.diaceutics.com/articles/when-will-pharma-appreciate-that-investment-in-diagnostics-boosts-therapy-roi
2021-03-23T11:34:20+00:00
https://www.diaceutics.com/articles/report-demonstrates-revenues-from-personalized-medicine-pm-enabled-drugs-continue-to-rise-counter-to-industry-perception
2021-03-23T11:34:21+00:00
https://www.diaceutics.com/articles/diaceutics-raises-a-further-4m-from-silicon-valley-bank-to-support-global-growth
2021-03-23T11:34:23+00:00
https://www.diaceutics.com/articles/podcast-oncology-patient-research
2021-03-23T11:34:24+00:00
https://www.diaceutics.com/articles/pharma-communication-and-education-for-stakeholders-personalized-medicine-what-pharma-should-do-to-get-ready-series
2021-03-23T11:34:30+00:00
https://www.diaceutics.com/articles/how-big-can-mercks-keytruda-be-in-lung-cancer-its-too-early-to-call-in-the-pdl1-arms-race
2021-03-23T11:34:36+00:00
https://www.diaceutics.com/articles/french-alk-study-helps-illuminate-the-high-negative-dollar-impact-of-single-test-strategies-with-companion-diagnostics
2021-03-23T11:34:37+00:00
https://www.diaceutics.com/articles/mystery-solved-what-is-the-cost-to-develop-and-launch-a-diagnostic
2022-10-06T17:33:20+00:00
https://www.diaceutics.com/articles/will-lab-benefit-managers-lbms-hinder-or-improve-access-to-precision-medicine-testing-in-the-us
2024-01-23T16:52:43+00:00
https://www.diaceutics.com/articles/the-evolving-role-of-liquid-biopsy-from-advanced-disease-monitoring-to-an-emerging-tool-for-early-cancer-management
2023-10-16T16:34:03+00:00
https://www.diaceutics.com/articles/emqn-cic-partners-with-diaceutics-to-implement-pilot-eqa-program-for-ophthalmological-disease-inherited-retinal-disorders-ird
2023-01-10T11:15:57+00:00
https://www.diaceutics.com/articles/the-diagnostic-testing-ecosystem-is-broken
2023-10-16T17:30:22+00:00
https://www.diaceutics.com/articles/esmo23-diaceutics-key-takeaways
2023-10-26T10:37:13+00:00
https://www.diaceutics.com/articles/cancer-immunotherapy-the-key-to-better-treatment-outcomes
2023-12-06T11:40:44+00:00
https://www.diaceutics.com/articles/match-rare-disease-patients-to-targeted-therapies-using-dxrx-signal
2023-02-07T09:32:11+00:00
https://www.diaceutics.com/articles/our-new-pm-catchphrase-like-it-learn-it-leverage-it
2023-01-24T12:17:14+00:00
https://www.diaceutics.com/articles/pharma-precision-medicine-readiness-report-2019
2023-01-24T11:24:13+00:00
https://www.diaceutics.com/articles/precision-medicine-readiness-report-2020-nsclc-an-axis-for-change
2023-01-24T11:24:33+00:00
https://www.diaceutics.com/articles/the-critical-role-of-lab-data-in-commercial-and-clinical-development-tactics
2023-02-07T09:32:57+00:00
https://www.diaceutics.com/articles/her2-scoring-assessment
2023-01-30T14:25:45+00:00
https://www.diaceutics.com/articles/$7million-multi-year-enterprise-engagements-for-data-subscription-announced
2023-01-30T11:50:25+00:00
https://www.diaceutics.com/articles/leveraging-dxrx-signal-to-drive-commercial-success
2023-02-07T09:33:28+00:00
https://www.diaceutics.com/articles/optimize-campaign-targeting-and-engagement-in-2023-with-a-new-data-strategy-
2023-02-07T17:07:49+00:00
https://www.diaceutics.com/articles/dr-markus-eckstein-shares-a-lab-perspective-on-the-impacts-of-a-dxrx-collaboration
2023-02-07T09:34:04+00:00
https://www.diaceutics.com/articles/when-rare-becomes-the-norm-part-2
2023-12-05T10:11:53+00:00
https://www.diaceutics.com/articles/failure-to-test-before-prescribing-precision-medicine-indicates-lack-of-awareness-of-biomarkers
2023-10-18T14:37:05+00:00
https://www.diaceutics.com/articles/overcoming-clinical-diagnostic-testing-barriers-in-precision-medicine
2023-10-16T17:13:04+00:00
https://www.diaceutics.com/articles/seamless-diagnostic-testing-12-recommendations-from-our-precision-medicine-expert-to-drive-your-launch-strategy-to-success
2024-01-23T16:05:21+00:00
https://www.diaceutics.com/articles/navigating-the-fda-pilot-program-in-oncology-drugs-with-in-vitro-diagnostic-tests-the-role-of-real-world-data
2023-10-16T16:29:30+00:00
https://www.diaceutics.com/articles/asco-daily-highlights-day-3
2023-10-16T16:44:45+00:00
https://www.diaceutics.com/articles/advancing-precision-medicine-in-cardiology-navigating-testing-challenges-for-enhanced-patient-outcomes
2023-12-05T10:10:14+00:00
https://www.diaceutics.com/articles/diaceutics-unveils-expert-advisory-panel-powering-its-industry-changing-diagnostic-network-dxrx
2023-10-16T17:08:21+00:00
https://www.diaceutics.com/articles/use-of-real-world-clinical-lab-data-to-reveal-asian-ntrk-fusion-test-availability-patterns
2023-10-16T17:15:57+00:00
https://www.diaceutics.com/articles/diaceutics-publishes-the-2019-diaceutics-pharma-precision-medicine-pm-readiness-report
2023-10-16T17:24:21+00:00
https://www.diaceutics.com/articles/asco-daily-highlights-day-1
2023-10-19T09:41:35+00:00
https://www.diaceutics.com/articles/shift-to-collaborative-mindset-required-to-optimize-the-patient-diagnostic-pathway-in-precision-medicine
2023-10-19T09:52:45+00:00
https://www.diaceutics.com/articles/multi-stakeholder-group-bring-a-unique-economic-solution-to-the-clinical-practice-gaps-holding-back-precision-medicine
2024-03-20T13:02:24+00:00
https://www.diaceutics.com/articles/will-fda-s-newly-launched-minimum-characteristics-pilot-program-drive-ldts-to-be-the-answer-to-better-testing-in-precision-medicine
2023-10-16T16:41:57+00:00
https://www.diaceutics.com/articles/precision-medicine-has-different-economics-at-play
2023-09-19T10:57:29+00:00
https://www.diaceutics.com/articles/liquid-biopsy
2023-10-16T16:50:42+00:00
https://www.diaceutics.com/articles/susanne-munksted-named-to-pharmavoice-100-list-of-most-inspiring-leaders-for-2023
2023-09-19T14:55:47+00:00
https://www.diaceutics.com/articles/asco-daily-highlights-day-2
2023-10-16T16:57:23+00:00
https://www.diaceutics.com/articles/collaboration-can-help-improve-reimbursement-challenges-in-the-pd-l1-testing-landscape
2023-10-16T17:20:13+00:00
https://www.diaceutics.com/articles/precision-medicine-highlights-from-ecp-2023
2023-09-21T08:35:28+00:00
https://www.diaceutics.com/articles/ryan-keeling-appointed-ceo-designate-of-diaceutics-plc
2023-09-25T17:03:38+00:00
https://www.diaceutics.com/articles/ffc3d664-04ab-4d01-a29c-03fe944bb44f
2024-01-11T16:38:39+00:00
https://www.diaceutics.com/articles/diaceutics-clinches-prestigious-uk-tech-award-for-best-use-of-technology-in-the-digital-economy
2023-11-13T16:31:23+00:00
https://www.diaceutics.com/articles/from-drug-discovery-to-delivery-ai-s-impact-on-pharma-and-precision-medicine-c9e24b7d-8995-47c0-a283-b23c83b46636
2023-12-04T15:23:11+00:00
https://www.diaceutics.com/articles/diaceutics-joins-best-of-british-conference
2023-12-04T09:56:24+00:00
https://www.diaceutics.com/careers/project-coordinator-eu-us-ni
2023-02-13T15:58:56+00:00